Get started

OPGN

OPGN 1M Decline -62% to $0.07. Rebound $0.14 and then $0.01Do you wear Fleece? Its going to be cold. OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
OShort
by TheCryptoChartWhisperer
OPGN 15min Scalpers editiontest OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It also engages in the development of molecular information products and services for global healthcare settings. It also offers guidance to clinicians about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The firms products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
OShort
by TheCryptoChartWhisperer
OPGN. P-Modeling Pt X-1 The Cajun WaveFunction of WonderWelcome Hyperspace Travelers. This is going to be one of the most profitable trades I ever engage in. I wish you to join me at your own risk. I know you will doubt what I am about to say.. But that is the funny thing about my work. Your doubt is my gain. OPGN Is going to enter a miraculous depth defying parabolic move that will cement OPGN as a heavyweight bio-technology stock. Part One is +200%. Part Two is +200%. Part One of OPGN is now active. ______________________________________________ Holding 38,215 Shares of OPGN @ Entry Price between $2.10 - $2.12. _____________________________________________________________ Confirmation of TP is Equalization of Mean Reversion. $7.60 -$6.60 is LEVEL ONE TP. Satisfying this equalization level brings in just under a quarter million dollars profit. +200% This IDEA only shows TP LEVEL ONE. $7.60 - $6.60. This is +200% from out current price of $2.47. Once we satisfy this TP LEVEL ONE, I will release the Public Chart for satisfying TP LEVEL TWO @ $15.00 - $11.00 on OPGN. Once we satisfy TP LEVEL TWO, I will release the Public Chart for satisfying TP LEVEL THREE @ $35.00 - $28.00 on OPGN. This is the First Approximation of Mean Reversion on a 1 Hour Vector Segment. I expect a profit capture of over half a million dollars by the end of my Trade Sequence on OPGN alone. If I satisfy ALL my TP LEVEL's I will make a total of 1.3 million dollars on my investment. _______________________________ Technical Components Explained. _______________________________ A Wave Function is split into two components. The first component is the dynamic parametric describing an underlying functional connectivity between Slope (S), Velocity (V), Pressure (P) and Mean Equalization (||#) of an actualized binary {1001:0110} over Time (Y) within Segment (TF). The second component is a Cyclic Approximation of the cyclical momentum of angular spin along a equalizing binary string. These mechanics shown are used to decode a wave function of a ecosystem that is multidimensional and algorithmically controlled. Algorithmic mechanics yields astounding evidence of geometric structure affinity to these types of ecosystems based upon rudimentary binary code used to power these vessels of manipulation. Thus, application is warranted. The Mean Reversion is the mean of the Segment TF of an actualized string binary. I have decoded two sets of wavefunctions in OPGN that guide its algorithmic movement. I use a variety of parametrics to tease out the algorithmic movements into geometric approximations specific to OPGN's inherent functional connectivity. OPGN has achieved orthogonality. OPGN has satisfied a structural integrity of approximations. OPGN has satisfied lower level dimensional Mean Reversion Levels. OPGN has significant structural integrity. Look at OCT-NOV-DEC of 2019. We now have a PERFECT MATCH between the previous structure and our current structure. This is NOT a coincidence. Do your own research. OPGN is a powerhouse of catalysts. Welcome to Hyperspace. Welcome to the 4th Industrial Revolution. The Cybernetic Era of Advancement. OPGN will consistently GREEN in a sea of RED. Global Depression is imminent. OPGN is primed. As of today, they have net positive cash flow, with FDA approval imminent on their flagship AMR gene panel. Check Press Releases for Pipeline of incoming catalysts. Doubters will be cry. Holders will fly. Join the Glitch in Hyperspace. Thanks for Pondering the Unknown with Me, Glitch420
OLong
by Glitch420
10
OPGN A Tale Of 2 FibsOPGN has slowly crept up ever since that insider buying in June. After meandering around the 786 fib line for weeks, the stock finally headed back toward that 618 fib line and...yet again...was rejected at that level. In general, momentum has been building in the stock but now with some attention, this 618 fib level could be an important one to keep an eye on for longs. You've also got the FDA review to think about as well. From June: " The company recently submitted an updated 510(k) summary to the FDA for its Acuitas AMR Gene Panel for isolates. It included all of the FDA’s previously requested updates and consistent with the FDA’s outlined timeline. OpGen was previously informed that the FDA intends to complete its review by the end of August ...Obviously, with infectious diseases taking up a lot of the news flow over the last year, diagnostics companies have grown in popularity. Along with subsidiaries Curetis GmbH and Ares Genetics GmbH, OpGen develops and commercializes molecular microbiology solutions to guide clinicians with rapid and actionable information about life-threatening infections...One of the main catalysts for this week is actually based on insider activity. A few Form 4s were filed on the 14th, showing insider buys this month. Both COO Johannes Bacher and CEO Oliver Schacht picked up a total of 40,000 shares for just over $90,000. Purchases were made at prices ranging from $2.22 to $2.30. " Quote Source & Read More: 5 Top Penny Stocks Insiders Decided To Buy In June 2021
O
by PennyStocks101
2
OPGN Would you buy something that was 1000x more expensive? 6/9/2020 Alliance Global Partners Reiterated Rating to Buy and target price to $5.00 OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. Aug 11 Reuters: OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers Aug 9 Reuters: OpGen Co-Markets COVID-19 Antibody Test Kit. OpGen is marketing and promoting the CELLSEARCH system, CELLSEARCH CEC kit, and certain COVID-19 related products that are sold and distributed by MSB on a non-exclusive basis Market cap. 34.511M Net income: -12.446M Annual Sales $3.50 million If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.
OLong
by TopgOptions
4
OPGN. P-Modeling Pt X. The Cajun's of Hyperspace TravelWelcome Hyperspace Traveler! This is Trial X on OPGN. Trial X is special. Come join me... This would be a great place to reverse. ^evil smile^. Let's see how this goes! Start//: Before Snapshot. End//: After Snapshot. 45 minute TF> Massive Harmonic Suppression.. Amplification imminent. This model adheres to Time-Series Failure is a necessary component of success. Entry Avg $2.70- $3.48 @12,100 shares. Target: $38.00 -$41.00 Knife Catch: ?? When:> Before April 20th. Approx Profit if Quantum Model is followed: $459,800 - $496,000 Why? Catalyst: Corvid-19 test kits, Merger, FDA approval, Diagnostics. Come for the laughs, Stay for the Art. ____________________________ If you are lurking, let me know. Thanks for Pondering the Unknown with Me, Glitch420
OLong
by Glitch420
16